Open AccessVaginal bromocriptine in hyperprolactinemic patients and puerperal women
Author(s) -
Jasonni Valerio Maria,
Raffelli Roberta,
March Adelina,
Frank Giorgio,
Flamigni Carlo
Publication year - 1991
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.3109/00016349109007166
Subject(s) - bromocriptine , medicine , obstetrics , gynecology , prolactin , hormone
Fifteen hyperprolactinemic and 7 puerperal women were treated with bromocriptine per vaginam (2.5‐5 mg) because of absolute intolerance to the oral administration of this drug. In both groups the prolactinemia was normalized without the typical side effects of bromocriptine. Three patients reported vaginal burning, but only one discontinued the therapy because of the intensity of the symptom. This study suggests that vaginal bromocriptine should be considered as a useful alternative for the treatment of hyperprolactinemia.